Ultrahuman
PrivateLast Round
Series C
Sep 3, 2026
Est. Valuation
$363M
Total Funding Raised
$195M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Ultrahuman operates in Healthcare & Life Sciences and is based in Bangalore. Its latest recorded funding round was a Series C round in September 2026.
Ultrahuman is a health technology company that develops and manufactures wearable devices and platforms for metabolic health, fitness, and sleep monitoring.
Sector
Healthcare & Life Sciences
Verticals
Consumer Electronics, Health IoT, Sports & Fitness, Medical Devices, Subscription Commerce
Business Model
B2C
Customer Profile
Hardware Sales, Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ultrahuman Comparables
Compare Ultrahuman with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Levels | 83% | |
| Oura | 83% | |
| Noise | 82% |
For institutional investors. Book with your work email.
Ultrahuman Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 3, 2026 | ||||
| Series C Extension | Jul 15, 2026 | ||||
| Series C | Mar 17, 2026 | ||||
| Debt | Nov 20, 2025 | ||||
| Early Funding | Apr 28, 2025 | ||||
Debt | Mar 20, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ultrahuman Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alteria Capital | Debt, Series C |
| Steadview Capital | Series A, Series B, Series C Extension |
| Rainmatter Capital Fund | Series A Extension |
| iSeed | Series A |
| Qualcomm Ventures | Series C |
| Panthera Capital Investments | Series B |
| Blume Ventures | Debt, Series C, Series A, Seed, Series B, Series C Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2026
$70M round led by Qualcomm Ventures
- Jul 15, 2026
$60M round led by Steadview Capital and Blume Ventures.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingNov 9, 2026
Ultrahuman Healthcare Pvt Ltd. eyes an AI-assisted system that combines heart rate, muscle activity, movement patterns, and body temperature to detect fatigue in athletes, potentially helping prevent injuries and inform training loads.
- partners_withNov 3, 2026
Ultrahuman Healthcare Pvt Ltd. partners with More Than Equal in India on Nov 3rd '26 to support an all-female driver development programme, with drivers and coaches using the Ultrahuman Ring to track sleep, training, and recovery.
- launchesOct 30, 2026
Ultrahuman Healthcare Pvt Ltd. introduces UltraSnap Charging Technology, a magnetic click-in system designed to make charging easier and operate at a lower temperature than conventional wireless charging.
- has_issues_withOct 24, 2026
Oura's latest Texas federal lawsuit claims Ultrahuman Healthcare Pvt Ltd.'s redesigned Ring Pro still infringes design and hardware patents; Ultrahuman Healthcare Pvt Ltd. says the ring remains available in the United States and plans to contest the allegations.
- has_issues_withOct 23, 2026
Oura says Ultrahuman Healthcare Pvt Ltd. infringes patents covering the Ring Pro’s curved battery, circuit board, magnets, and sensors, and files suit on Oct 22nd '26.
For institutional investors. Book with your work email.
Ultrahuman Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ultrahuman's valuation, stock price, and market status.
Is Ultrahuman a public or private company?
Ultrahuman is a private company.
What is the current stock price of Ultrahuman?
Ultrahuman is a private company, so its shares have no public market price. Caplight tracks Ultrahuman's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ultrahuman worth (valuation)?
Ultrahuman's valuation is estimated at $363.0M based on funding round data.
Can I buy Ultrahuman stock?
Ultrahuman shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ultrahuman's last funding round?
Ultrahuman's most recent funding round was Series C on September 3, 2026.
Who are the main investors in Ultrahuman?
Key investors in Ultrahuman include Steadview Capital, Qualcomm Ventures, Blume Ventures, WestBridge Capital, Nexus Venture Partners.
Will Ultrahuman IPO soon?
No public IPO plans have been announced for Ultrahuman.
How can I track Ultrahuman secondary market activity?
Caplight tracks bids, offers, and trades in Ultrahuman's shares on secondary markets.